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Abstract
Hypertension is associated with atherosclerosis and cardiac and vascular structural and functional changes.
Myocardial ischemia may arise in hypertension independent of coronary artery disease through an interaction
between several pathophysiological mechanisms, including left ventricular hypertrophy, increased arterial stiffness
and reduced coronary flow reserve associated with microvascular disease and endothelial dysfunction. The present
case report demonstrates how contrast stress echocardiography can be used to diagnose myocardial ischemia in a
hypertensive patient with angina pectoris but without significant obstructive coronary artery disease. The
myocardial ischemia was due to severe resistant hypertension complicated with concentric left ventricular
hypertrophy and increased arterial stiffness.
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Introduction
Hypertension is associated with atherosclerosis and car-
diovascular structural and functional changes predispos-
ing hypertensive patients to myocardial ischemia also in
the absence of significant epicardial coronary artery dis-
ease through a number of pathophysiological mechan-
isms. Increased arterial stiffness is common in
hypertension, and associated with structural changes in
the left ventricle, typically concentric hypertrophy or
concentric remodelling [1-3]. Increased arterial stiffness
may also contribute to myocardial ischemia as a conse-
quence of the earlier return of reflection waves in stiff
arteries and hence a reduction in diastolic myocardial
perfusion pressure [4]. The combination of muscle-
capillary mismatch due to concentric left ventricular
hypertrophy and reduced diastolic myocardial perfusion
pressure due to increased arterial stiffness may lead to
severe myocardial ischemia. Typically these patients
develop myocardial fibrosis with subsequent deteriora-
tion of diastolic and systolic function and finally clinical
heart failure [5]. In addition, coronary microvascular
dysfunction is common in hypertension and contributes
to left ventricular ischemia [6]. Recently the diagnostic
and prognostic value of Doppler derived coronary flow
reserve measurement by vasodilator stress echocardio-
graphy was demonstrated [7]. However, myocardial
hypoperfusion may also be directly visualized by con-
trast stress echocardiography [8]. This case report
demonstrates the usefulness of including contrast stress
echocardiography in multimodality cardiovascular ima-
ging in diagnostic work-up of a patient with refractory
hypertension presenting with exercise induced chest
pain.
Case Presentation
A 42-years old African man was referred for stress echo-
cardiography due to exercise induced chest pain. Clini-
cally he had resistant hypertension based on sitting
blood pressure (140/100 mmHg) in spite of treatment
with 4 different antihypertensive drugs, including a b-
blocker, calcium-blocker, diuretic and angiotensin-2
blocker [9]. Twenty-four hour ambulatory blood pres-
sure was on average 127/85 mmHg, but 39% of systolic
and 64% of diastolic measurements were elevated, and
the diurnal variation was reduced. Further diagnostic
work-up did not reveal any signs of secondary hyperten-
sion. His medical history included complete recovery
after coiling of a cerebral aneurysm associated with sub-
arachnoid bleeding in 2004. There was a family history* Correspondence: mai.tone.lonnebakken@helse-bergen.no1Department of Heart Disease, Haukeland University Hospital, Bergen,
Norway
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of hypertension and the patient had undergone coronary
angiography in 2006 which was reported as normal.
The electrocardiogram was consistent with left ventri-
cular hypertrophy by Sokolow-Lyon criteria. The renal
function was slightly reduced with elevated serum crea-
tinine level (112 μmol/l, normal reference range 60-105
μmol/l) but normal estimated glomerular filtration rate
>60 ml/min/1.73 m2. No micro albuminuria was present
(albumin/creatinine ratio 1.2 mg/mmol, normal refer-
ence < 2.5 mg/mmol). Echocardiography demonstrated
concentric left ventricular hypertrophy with left ventri-
cular mass index 215 g/m2 (normal reference value in
men <116 g/m2) and relative wall thickness 0.52 (normal
reference value <0.43) (Figure 1). Left ventricular ejec-
tion fraction was normal, but longitudinal function was
reduced, consistent with reduced systolic left ventricular
myocardial function and diastolic dysfunction grade 1
with normal filling pressure was also found. Left ventri-
cular end-diastolic pressure and peak systolic left ventri-
cular wall stress was in high normal range, 12 mmHg
and 440 kdynes/cm2 (normal range 275-451 kdynes/
cm2), respectively [10-12]
Pulse wave analysis by aplanation tonometry (Sphyg-
moCor®, AtCor Medical Pty. Ltd, Sydney, Australia), of
carotid and femoral arterial pressure waves demonstrated
that central aortic systolic blood pressure and pulse pres-
sure were in the normal range on current medication
(143 mmHg and 41 mmHg, respectively) (Figure 2) [13].
The augmentation pressure was elevated (12 mmHg) and
the augmentation index was in the upper normal range
(12 mmHg or 25% when adjusted for heart rate). Both
ejection duration (31%) and sub-endocardial viability
ratio (198%) were normal. However, age adjusted pulse
wave velocity was high (11.6 ± 1.1 m/s) consistent with
increased arterial stiffness (Figure 2) [2,14].
Contrast stress echocardiography with real-time low-
mechanical index imaging and destruction replenish-
ment, using Luminity® (Lantheus Medical Imaging,
North Billerica, Massachusetts, USA) ultrasound con-
trast agent and a standardized dobutamine atropine
stress protocol, was performed. At rest wall motion
score in all 17-segments of the left ventricle was normal,
while globally delayed contrast enhancement in the left
ventricular myocardium was found, in particular in the
apical septum (Figure 3, Additional file 1). During dobu-
tamine-atropine stress the patient experienced chest
pain. No stress induced wall motion abnormalities were
detected. However, the contrast enhancement was
further delayed during stress, in particularly in the apical
septum and anterior wall (Figure 3, Additional file 2).
Awaiting further examination with coronary angiogra-
phy he was hospitalized with acute chest pain without
electrocardiographic changes, but slightly elevated
serum troponin T level (18-19 mmol/l, reference value
<15 mmol/l) without typical rise and fall pattern. Coron-
ary angiography demonstrated non-obstructive coronary
artery disease with non-significant changes in the left
anterior descending coronary artery (Figure 4).
Discussion
This case report demonstrates how contrast stress echo-
cardiography may be used in cardiovascular multimodality
Figure 1 Echocardiography demonstrating concentric left ventricular hypertrophy in parasternal long-axis and apical 4-chamber view.
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imaging work-up of hypertensive patients with chest pain
and non-obstructive coronary artery disease. The present
patient had symptomatic severe myocardial ischemia
documented by contrast echocardiography in the absence
of significant angiographic coronary artery disease [15].
Myocardial ischemia was induced through an interaction
between non-obstructive coronary artery disease,
increased arterial stiffness and concentric left ventricular
hypertrophy, three well known types of cardiovascular
end-organ damage in hypertension [9].
Hypertension is recognized as a risk factor for devel-
opment of atherosclerosis including vascular smooth
Figure 2 Carotid and aortic pulse wave analysis and carotid-femoral pulse wave velocity assessed by SphygmoCor®.
Lønnebakken et al. Cardiovascular Ultrasound 2011, 9:33
http://www.cardiovascularultrasound.com/content/9/1/33
Page 3 of 6
muscle growth and lengthening of arteries (depicted as
tortuous coronary arteries in Figure 4) and endothelial
dysfunction [16]. Non-obstructive coronary artery dis-
ease is not uncommon in hypertensive patients
undergoing coronary angiography due to chest pain, and
detection of reduced Doppler derived coronary flow
reserve during vasodilator stress echocardiography,
reflecting microvascular disease and endothelial
Figure 3 Contrast echocardiography in apical 4-chamber view at rest and during peak dobutamine-atropine stress demonstrating
delayed contrast enhancement in left ventricular myocardium.
Figure 4 Coronary angiography demonstrating left dominant coronary artery circulation and a hypoplastic right coronary artery, both
without significant epicardial coronary artery stenoses.
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dysfunction in such patients, has been shown to predict
worse prognosis in spite of normal wall motion score
during conventional stress echocardiography [7,17].
Increased arterial stiffness is a well-known marker of
cardiovascular risk and disease in hypertension [4]. Cur-
rent guidelines recommend assessment of arterial stiff-
ness from carotid-femoral artery pulse wave velocity, and
this was high for age in this patient consistent with
increased arterial stiffness [9]. The increased stiffness
causes refection waves to return earlier to proximal aorta
and thereby reduce the myocardial diastolic perfusion
pressure. The myocardial diastolic perfusion pressure is
of crucial importance to the perfusion of the myocar-
dium, particularly during exercise, due to increased heart
rate and hence shortening of the diastole.
Concentric left ventricular hypertrophy is the prognos-
tically most unfavourable geometric pattern found in
hypertension and particularly common in hypertensive
patients of African origin [18]. Hypertension increases
the left ventricular workload and thereby the oxygen
demands of the myocardium. In particular concentric
hypertrophy is also associated with a muscle-capillary
mismatch as well as high endocardial wall stress which
may contribute to the diagnosed myocardial ischemia in
our patient [5]. Chronic ischemia may promote struc-
tural changes in the myocardium and development of
fibrosis that together with functional myocardial impair-
ment due to ischemia induced metabolic changes causes
heart failure, the end stage of hypertensive heart disease.
Contrast stress echocardiography is particularly suited
to detect myocardial ischemia. In accordance with cur-
rent guidelines a contrast agent should be added during
stress echocardiography when 2 or more left ventricular
segments cannot be sufficiently evaluated [19,20]. This
does not only improve wall motion assessment [20] but
allows simultaneous evaluation of myocardial ischemia
as contrast microbubbles are isolated intravascular tra-
cers directly reflecting myocardial perfusion and capil-
lary density [20]. Even if direct quantification of
myocardial perfusion has proven difficult so far, qualita-
tive detection of delayed contrast enhancement has been
shown to be more sensitive to detect coronary artery
disease than wall motion alone [21]. As ultrasound con-
trast often is indicated due to image quality, simulta-
neous assessment of myocardial perfusion adds
important information on regional myocardial ischemia
with high spatial resolution without extra cost. Further-
more, the safety of contrast echocardiography and
potential side effects are well documented [20].
Also in hypertensive patients, development of wall
motion abnormalities during stress echocardiography is
associated with increased cardiovascular event rate [22].
Hypertension is associated with both increased prevalence
of severe coronary artery disease as well as increased
prevalence of non-obstructive ischemic heart disease.
Echocardiographic diagnosis of microvascular disease
should not be made unless obstructive coronary artery dis-
ease has been ruled out by coronary angiography or cor-
onary computer tomographic angiography [22,23].
Diagnosis of non-obstructive ischemic heart disease is
challenging and requires use of multimodality imaging as
demonstrated by the present case. In particular vasodila-
tion stress echocardiography assessing coronary flow
reserve and myocardial perfusion assessment by contrast
stress echocardiography or magnetic resonance imaging
have proven useful in diagnosis of non-obstructive
ischemic heart disease, while this diagnosis may often be
missed on conventional stress echocardiography assessing
only wall motion abnormality [7,22,23]. Coronary flow
reserve <1.91 during adenosine stress has been associated
with increased cardiovascular risk in hypertensive patients
independent of the presence of wall motion abnormalities
[7]. Furthermore, a coronary computer tomographic
angiography study recently documented reduced prog-
nosis in women with non-obstructive ischemic heart dis-
ease [24]. Therefore, diagnosing symptomatic myocardial
ischemia in hypertensive patients without significant cor-
onary artery disease has important clinical implications
and should initiate aggressive anti-hypertensive and anti-
ischemic treatment as well as risk factor modification to
improve symptoms and prognosis. In particular, perform-
ing 24 hour ambulatory blood pressure recording for opti-
mal assessment of blood pressure is important in resistant
hypertension. Improved blood pressure control in resistant
hypertension may be obtained by adding a small dosage of
an aldosterone blocker or amiloride, the latter particularly
effective in hypertension in Africans [9]. Furthermore,
treatment with angiotensin converting enzyme inhibitors
or statins improves microvascular function and symptoms
in non-obstructive ischemic heart disease [25].
Conclusion
Chronic uncontrolled hypertension is associated with devel-
opment of cardiovascular complications including athero-
sclerosis, left ventricular hypertrophy, arterial stiffening and
microvascular dysfunction. This can cause symptomatic
myocardial ischemia even in the absence of significant epi-
cardial coronary artery stenoses. In hypertensive patients
with exercise induced chest pain and non-obstructive cor-
onary artery disease, additional multimodality imaging
including contrast stress echocardiography and assessment
of vascular function is useful to identify the cause of symp-
toms and optimally manage such patients.
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Additional material
Additional file 1: Contrast echocardiography at baseline
demonstrating the delayed contrast enhancement, in particularly in
the distal part of intraventricular septum in an apical 4-chamber
view.
Additional file 2: Contrast echocardiography at peak dobutamine-
atropine stress demonstrating the globally delayed contrast
enhancement in apical 4-chamber view.
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